BW VACCINE SURGE MEETING 3 DEC 90

File: 120396_sep96_decls63_0002.txt
Page: 0002
Total Pages: 3

Subject: BW VACCINE SURGE MEETING  3 DEC 90                              

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003203

Folder Title: BW VACCINE SURGE MEETING                                                                        

Document Number:          1

Folder SEQ  #:         15













          DASG-PSZ
          SUBJECT: BW VACCINE SURGE MEETING






              e. Michigan Public Health Service (New Contract).
               (1) This is the same organization that is currently
          producing the anthrax vaccine (see a). Michigan is taking the
          individual botulinum serotypes and combining them to a
          pentavalent vaccine and packaging multi-dose vials.   They are
          able to produce botulinum monovalent vaccine as well within
          existing space and facilities but renovation is needed. It is
          unclear how much this would cost or what is required. A proposal
          is due this week.

              (2) It is possible that once the
          is producing the large amounts of anthrax vaccine, by mid March,
          that the Michigan anthrax vaccine production can be stopped and
          the fermenters converted to producing serotypes for the
          pentavalent botulinum vaccine. There is no estimate on money
          requirements but this should be available within a week.
              f. USAMRIID (Botulinum Vaccine Produ:twioon - Colonel Ronald
          WilliaMB, Commander of USAMRIID briefed th   ri ing group on the
          pros and cons of converting to such production. His briefing is
          at Enclosure 2. Essentially he stated that with relatively minor
          modification production of two serotypes could begin within 30
          days. Personnel are already vaccinated to meet good
          manufacturing standards and good labor standards, however, it
          would require six to seven months of major facility renovation.
          He was also concerned about the change in the mission from one of
          research to that of production and the lack of experience anyone
          there has had with production. He referred to a group of
          consultants experienced in vaccine production who had toured the
          facility and would make recommendations as to the feasibility of
a meeting was set for later in the week to
          further discuss the issue and make the required recommendation to
          ASD(HA).







                                 UNCLASSIFIED

Document 3 f:/Week-36/BX003203/BW VACCINE SURGE MEETING/bw vaccine surge meeting 3 dec 90:1125961012453
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = BW VACCINE SURGE MEETING
Folder Seq # = 15
Subject = BW VACCINE SURGE MEETING 3 DEC 90
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 25-NOV-1996